S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   303.85 (+0.13%)
AAPL   123.08 (+0.29%)
MSFT   215.37 (-0.39%)
FB   287.52 (+0.34%)
GOOGL   1,824.97 (+1.65%)
AMZN   3,203.53 (-0.51%)
TSLA   568.82 (-2.73%)
NVDA   541.78 (+1.15%)
BABA   261.32 (-1.02%)
CGC   28.18 (+5.74%)
GE   10.43 (+2.76%)
MU   69.11 (+3.03%)
AMD   93.74 (+1.20%)
T   29.09 (+0.76%)
NIO   47.98 (+5.78%)
F   9.20 (-0.43%)
ACB   10.95 (+12.31%)
NFLX   503.38 (-0.24%)
BA   223.85 (+5.09%)
GILD   61.13 (+0.02%)
DIS   153.61 (+2.79%)
S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   303.85 (+0.13%)
AAPL   123.08 (+0.29%)
MSFT   215.37 (-0.39%)
FB   287.52 (+0.34%)
GOOGL   1,824.97 (+1.65%)
AMZN   3,203.53 (-0.51%)
TSLA   568.82 (-2.73%)
NVDA   541.78 (+1.15%)
BABA   261.32 (-1.02%)
CGC   28.18 (+5.74%)
GE   10.43 (+2.76%)
MU   69.11 (+3.03%)
AMD   93.74 (+1.20%)
T   29.09 (+0.76%)
NIO   47.98 (+5.78%)
F   9.20 (-0.43%)
ACB   10.95 (+12.31%)
NFLX   503.38 (-0.24%)
BA   223.85 (+5.09%)
GILD   61.13 (+0.02%)
DIS   153.61 (+2.79%)
S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   303.85 (+0.13%)
AAPL   123.08 (+0.29%)
MSFT   215.37 (-0.39%)
FB   287.52 (+0.34%)
GOOGL   1,824.97 (+1.65%)
AMZN   3,203.53 (-0.51%)
TSLA   568.82 (-2.73%)
NVDA   541.78 (+1.15%)
BABA   261.32 (-1.02%)
CGC   28.18 (+5.74%)
GE   10.43 (+2.76%)
MU   69.11 (+3.03%)
AMD   93.74 (+1.20%)
T   29.09 (+0.76%)
NIO   47.98 (+5.78%)
F   9.20 (-0.43%)
ACB   10.95 (+12.31%)
NFLX   503.38 (-0.24%)
BA   223.85 (+5.09%)
GILD   61.13 (+0.02%)
DIS   153.61 (+2.79%)
S&P 500   3,669.01 (+0.18%)
DOW   29,883.79 (+0.20%)
QQQ   303.85 (+0.13%)
AAPL   123.08 (+0.29%)
MSFT   215.37 (-0.39%)
FB   287.52 (+0.34%)
GOOGL   1,824.97 (+1.65%)
AMZN   3,203.53 (-0.51%)
TSLA   568.82 (-2.73%)
NVDA   541.78 (+1.15%)
BABA   261.32 (-1.02%)
CGC   28.18 (+5.74%)
GE   10.43 (+2.76%)
MU   69.11 (+3.03%)
AMD   93.74 (+1.20%)
T   29.09 (+0.76%)
NIO   47.98 (+5.78%)
F   9.20 (-0.43%)
ACB   10.95 (+12.31%)
NFLX   503.38 (-0.24%)
BA   223.85 (+5.09%)
GILD   61.13 (+0.02%)
DIS   153.61 (+2.79%)
Log in
NYSE:CVS

CVS Health Stock Forecast, Price & News

$69.63
+2.09 (+3.09 %)
(As of 12/2/2020 04:34 PM ET)
Add
Compare
Today's Range
$67.45
Now: $69.63
$70.29
50-Day Range
$55.93
MA: $63.39
$73.47
52-Week Range
$52.04
Now: $69.63
$76.44
Volume8.09 million shs
Average Volume8.86 million shs
Market Capitalization$91.14 billion
P/E Ratio11.51
Dividend Yield2.96%
Beta0.69
CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans (PDPs), Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, beauty and personal care products, and cosmetics; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2019, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. The company was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 3.2Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.34 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
CUSIP12665010
Phone401-765-1500
Employees290,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$256.78 billion
Cash Flow$10.78 per share
Book Value$52.80 per share

Profitability

Net Income$6.63 billion

Miscellaneous

Outstanding Shares1,308,914,000
Market Cap$91.14 billion
Next Earnings Date2/10/2021 (Estimated)
OptionableOptionable
$69.63
+2.09 (+3.09 %)
(As of 12/2/2020 04:34 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CVS Health (NYSE:CVS) Frequently Asked Questions

How has CVS Health's stock price been impacted by COVID-19?

CVS Health's stock was trading at $61.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CVS shares have increased by 13.7% and is now trading at $69.73.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of CVS Health?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CVS Health
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than CVS Health?

Wall Street analysts have given CVS Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CVS Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is CVS Health's next earnings date?

CVS Health is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021.
View our earnings forecast for CVS Health
.

How were CVS Health's earnings last quarter?

CVS Health Co. (NYSE:CVS) released its quarterly earnings data on Wednesday, November, 11th. The pharmacy operator reported $1.66 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.33 by $0.33. The pharmacy operator had revenue of $67.05 billion for the quarter, compared to analysts' expectations of $66.54 billion. CVS Health had a net margin of 2.99% and a return on equity of 15.60%. CVS Health's revenue was up 3.5% compared to the same quarter last year. During the same period last year, the company posted $1.84 EPS.
View CVS Health's earnings history
.

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health declared a quarterly dividend on Wednesday, October 7th. Stockholders of record on Thursday, October 22nd will be given a dividend of $0.50 per share on Monday, November 2nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.87%. The ex-dividend date of this dividend is Wednesday, October 21st.
View CVS Health's dividend history
.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health updated its FY20 earnings guidance on Friday, November, 6th. The company provided earnings per share guidance of $7.35-7.42 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.23.

What price target have analysts set for CVS?

16 brokers have issued 12-month price targets for CVS Health's shares. Their forecasts range from $66.00 to $101.00. On average, they expect CVS Health's stock price to reach $82.43 in the next year. This suggests a possible upside of 18.2% from the stock's current price.
View analysts' price targets for CVS Health
.

Are investors shorting CVS Health?

CVS Health saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 16,930,000 shares, a decline of 14.8% from the October 31st total of 19,870,000 shares. Based on an average trading volume of 9,080,000 shares, the short-interest ratio is presently 1.9 days.
View CVS Health's Short Interest
.

Who are some of CVS Health's key competitors?

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), The Walt Disney (DIS), Johnson & Johnson (JNJ), NVIDIA (NVDA), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA) and The Home Depot (HD).

Who are CVS Health's key executives?

CVS Health's management team includes the following people:
  • Mr. Larry J. Merlo, Pres, CEO & Director (Age 64, Pay $12.83M)
  • Ms. Eva C. Boratto, Exec. VP & CFO (Age 53, Pay $4.56M)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 64, Pay $7.55M)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 56, Pay $5.78M)
  • Mr. James David Clark, Sr. VP, Controller & Chief Accounting Officer (Age 55)
  • Ms. Valerie C. Haertel, Sr. VP of Investor Relations
  • Mr. David A. Falkowski, Exec. VP & Chief Compliance Officer
  • Ms. Lisa G. Bisaccia, Exec. VP & Chief HR Officer (Age 64)
  • Mr. Troyen A. Brennan M.D., M.P.H., J.D., Exec. VP & Chief Medical Officer (Age 65)
  • Mr. Joshua Matthew Flum, Exec. VP of Enterprise Strategy & Digital (Age 50)

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.66%), State Street Corp (4.32%), Morgan Stanley (1.89%), Charles Schwab Investment Management Inc. (0.83%), Veritas Asset Management LLP (0.82%) and Nuveen Asset Management LLC (0.64%). Company insiders that own CVS Health stock include Alan Lotvin, C David Brown II, David W Dorman, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo, Troyen A Brennan and Vost Collin.
View institutional ownership trends for CVS Health
.

Which major investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including DAVENPORT & Co LLC, Alta Capital Management LLC, Nuveen Asset Management LLC, AJO LP, State Street Corp, Charles Schwab Investment Management Inc., AQR Capital Management LLC, and Lord Abbett & CO. LLC. Company insiders that have sold CVS Health company stock in the last year include Alan Lotvin, James David Clark, Jonathan C Roberts, and Larry J Merlo.
View insider buying and selling activity for CVS Health
.

Which major investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Squarepoint Ops LLC, CIBC Private Wealth Group LLC, Neuberger Berman Group LLC, MUFG Securities EMEA plc, and Robeco Institutional Asset Management B.V.. Company insiders that have bought CVS Health stock in the last two years include Alan Lotvin, C David Brown II, David W Dorman, and Edward J Ludwig.
View insider buying and selling activity for CVS Health
.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $69.73.

How big of a company is CVS Health?

CVS Health has a market capitalization of $91.27 billion and generates $256.78 billion in revenue each year. The pharmacy operator earns $6.63 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 290,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.